<![CDATA[Hansa Biopharma — Maj 2022]]>Analyshusens aktiefavoriter - Maj 2022 (Martin Hallström Marknadsstrateg Swedbank Analys):

https://www.swedbank-aktiellt.se/blogg/hallstrom/znhyao.csp

]]>https://dev.proinvestor.com/forum/topic/400726/hansa-biopharma-maj-2022RSS for NodeSat, 06 Jun 2026 08:16:05 GMTTue, 03 May 2022 09:24:00 GMT60<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Fri, 27 May 2022 05:06:21 GMT]]>JA, aggregerede shortpositioner 🙂

Men den aktuelle liste (25/5) er også bagud hele tiden. Fx MILLENNIUM INTERNATIONAL MANAGEMENT har øget igår (26/5).

]]>https://dev.proinvestor.com/forum/post/8006219https://dev.proinvestor.com/forum/post/8006219Fri, 27 May 2022 05:06:21 GMT<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Thu, 26 May 2022 04:35:45 GMT]]>FI er begyndt at opgive shortpositioner over 0,1 %, nuværende shortpositioner 6,48 %.

]]>https://dev.proinvestor.com/forum/post/8006218https://dev.proinvestor.com/forum/post/8006218Thu, 26 May 2022 04:35:45 GMT<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Wed, 25 May 2022 07:16:04 GMT]]>Fra 17:00 min. og frem spørgsmål og svar!

]]>https://dev.proinvestor.com/forum/post/8006216https://dev.proinvestor.com/forum/post/8006216Wed, 25 May 2022 07:16:04 GMT<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Wed, 25 May 2022 07:13:31 GMT]]>Hansa Biopharma - ABGSC Life Summit May 18 2022

]]>https://dev.proinvestor.com/forum/post/8006211https://dev.proinvestor.com/forum/post/8006211Wed, 25 May 2022 07:13:31 GMT<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Tue, 24 May 2022 10:20:02 GMT]]>"Vi förväntar oss därmed att data från studien kan presenteras innan årets slut."

]]>https://dev.proinvestor.com/forum/post/8006213https://dev.proinvestor.com/forum/post/8006213Tue, 24 May 2022 10:20:02 GMT<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Tue, 24 May 2022 10:18:27 GMT]]>Analyskommentar – AMR-studien fullrekryterad (Analys | 23 May 2022 | Hansa Biopharma)

Erik Penser kommentar:

"Vi ser goda förutsättningar för en positiv utläsning från studien givet imlifidases uppvisade förmåga att snabbt eliminera IgG-antikroppar."

]]>https://dev.proinvestor.com/forum/post/8006217https://dev.proinvestor.com/forum/post/8006217Tue, 24 May 2022 10:18:27 GMT<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Mon, 23 May 2022 04:29:24 GMT]]>Hansa Biopharma completes enrollment in imlifidase phase 2 study in antibody mediated rejection (AMR) episodes post kidney transplantation

https://investors.hansabiopharma.com/English/press-releases/press-releases-details/2022/Hansa-Biopharma-completes-enrollment-in-imlifidase-phase-2-study-in-antibody-mediated-rejection-AMR-episodes-post-kidney-transplantation/default.aspx

]]>https://dev.proinvestor.com/forum/post/8006210https://dev.proinvestor.com/forum/post/8006210Mon, 23 May 2022 04:29:24 GMT<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Wed, 18 May 2022 10:06:59 GMT]]>Tak @MBCruise...Så håber vi på positive resultater når de engang kommer:-)

]]>https://dev.proinvestor.com/forum/post/8006207https://dev.proinvestor.com/forum/post/8006207Wed, 18 May 2022 10:06:59 GMT<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Wed, 18 May 2022 06:02:45 GMT]]>@Staldkal - De afventer at Sarepta forhåbentlig går videre i klinikken, hvilket burde udløse milestones. Som jeg husker det forventer man beslutning i løbet af efteråret

]]>https://dev.proinvestor.com/forum/post/8006209https://dev.proinvestor.com/forum/post/8006209Wed, 18 May 2022 06:02:45 GMT<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Wed, 18 May 2022 04:41:05 GMT]]>Intet nyt er vel godt nyt. Ting tager tid, især i biotek 🙂

https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-signs-agreement-hansa-biopharma-imlifidase

(Sarepta Therapeutics Signs Agreement with Hansa Biopharma for Imlifidase)

]]>https://dev.proinvestor.com/forum/post/8006206https://dev.proinvestor.com/forum/post/8006206Wed, 18 May 2022 04:41:05 GMT<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Tue, 17 May 2022 08:49:20 GMT]]>Er der nogen der har en ide om hvordan samarbejdet med Sarepta forløber.

]]>https://dev.proinvestor.com/forum/post/8006208https://dev.proinvestor.com/forum/post/8006208Tue, 17 May 2022 08:49:20 GMT<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Mon, 16 May 2022 16:27:03 GMT]]>Endnu en god nyhed fra Hansa. Frygter kursen
den dag der kommer en dårlig nyhed?

]]>https://dev.proinvestor.com/forum/post/8006212https://dev.proinvestor.com/forum/post/8006212Mon, 16 May 2022 16:27:03 GMT<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Mon, 16 May 2022 04:53:58 GMT]]>Hansa Biopharma announces temporary marketing authorization in Switzerland for Idefirix[®] (imlifidase) in kidney transplantation

https://investors.hansabiopharma.com/English/press-releases/press-releases-details/2022/Hansa-Biopharma-announces-temporary-marketing-authorization-in-Switzerland-for-Idefirix-imlifidase-in-kidney-transplantation/default.aspx

]]>https://dev.proinvestor.com/forum/post/8006215https://dev.proinvestor.com/forum/post/8006215Mon, 16 May 2022 04:53:58 GMT<![CDATA[Reply to Hansa Biopharma — Maj 2022 on Sat, 14 May 2022 15:11:23 GMT]]>Test

]]>https://dev.proinvestor.com/forum/post/8006214https://dev.proinvestor.com/forum/post/8006214Sat, 14 May 2022 15:11:23 GMT